First-in-human (FIH) trials

Major pharma player Lonza has launched an integrated service to help address bioavailability challenges with drug substance, solid-state characterisation and drug product for first-in-human studies. Read more


Torkel Gren, Recipharm and Anders Millerhovf, CTC Clinical Trial Consultants discuss the steps needed for drug formulation during first-in-human (FIH) trials, if regulatory approval is to be achieved. Read more

, Opinion